Clinical and Translational Medicine, 2024 Efficacy and safety of pyrotinib combined with albumin‐bound paclitaxel as first‐line treatment for HER2‐positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single‐arm, phase 2 prospective clinical trial Man X., Huang J., Sun S. et al. Olink Target 96OncologyPathophysiologyPlasma | | | | |
JHLT Open, 2024 Proteomics early after heart transplantation and relation to coronary intimal changes and prognosis Dalsgaard R., Clemmensen T., Eiskjær H. et al. Olink Target 96CVDPatient StratificationPlasma | | | | |
BMC Medicine, 2024 Peripheral GFAP and NfL as early biomarkers for dementia: longitudinal insights from the UK Biobank Wang X., Shi Z., Qiu Y. et al. Olink Explore 3072/384NeurologyPatient StratificationPlasma | | | | |
Clinical Immunology, 2024 Serum proteomics reveals hemophagocytic lymphohistiocytosis-like phenotype in a subset of patients with multisystem inflammatory syndrome in children Tulling A., Holierhoek M., Jansen-Hoogendijk A. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesInfectious DiseasesPathophysiologyPatient StratificationSerum | | | | |
PROTEOMICS – Clinical Applications, 2024 Methods and clinical biomarker discovery for targeted proteomics using Olink technology Wang H., Zhao T., Zeng J. et al. Wider Proteomics StudiesReview/editorial | | | | |
Immunology & Cell Biology, 2024 Proteomics screening after pediatric allogenic hematopoietic stem cell transplantation reveals an association between increased expression of inhibitory receptor FCRL6 on γδ T cells and cytomegalovirus reactivation Alexandersson A., Venäläinen M., Heikkilä N. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationPlasma | | | | |
Frontiers in Immunology, 2024 Plasma proteomics analysis of Chinese HIV-1 infected individuals focusing on the immune and inflammatory factors afford insight into the viral control mechanism Ni W., Ren L., Liao L. et al. Olink Target 96Infectious DiseasesPathophysiologyPlasma | | | | |
BMJ Oncology, 2024 First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumours Naing A., Papadopoulos K., Pishvaian M. et al. Olink Target 96OncologyPathophysiologyPlasma | | | | |
Ticks and Tick-borne Diseases, 2024 Diagnostic patterns of serum inflammatory protein markers in children with Lyme neuroborreliosis Fredriksson T., Brudin L., Henningsson A. et al. Olink Target 96Infectious DiseasesPatient StratificationSerum | | | | |
Biomolecules, 2024 GlycA and CRP Are Genetically Correlated: Insight into the Genetic Architecture of Inflammageing Kasher M., Freidin M., Williams F. et al. Olink Target 96Immunological & Inflammatory DiseasesAgingPathophysiologyBlood | | | | |
Journal of the European Academy of Dermatology and Venereology, 2024 Exposure–response relationship of guselkumab and the potential of serum proteomics in identifying predictive biomarker candidates in psoriasis Soenen R., Schots L., Wang Z. et al. Olink Target 96Dermatological DiseasesPatient StratificationSerum | | | | |
Clinical Immunology, 2024 Proteomic mapping identifies serum marker signatures associated with MIS-C specific hyperinflammation and cardiovascular manifestation Reiter A., Verweyen E., Queste E. et al. Olink Target 96Immunological & Inflammatory DiseasesInfectious DiseasesPathophysiologySerum | | | | |
JCI Insight, 2024 Modulation of innate immune response to mRNA vaccination after SARS-CoV-2 infection or sequential vaccination in humans Hellgren F., Rosdahl A., Arcoverde Cerveira R. et al. Olink Target 96Infectious DiseasesPathophysiologyCell Culture Supernatant | | | | |
Heart & Lung, 2024 Causal role of circulating inflammatory cytokines in cardiac diseases, structure and function Ruan W., Zhou X., Liu H. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
Heliyon, 2024 Identification of endophenotypes supporting outcome prediction in hemodialysis patients based on mechanistic markers of statin treatment Leierer J., Salib M., Evgeniou M. et al. Olink Target 96CVDNephrologyPatient StratificationPlasma | | | | |
Brain, Behavior, and Immunity, 2024 Plasma proteomic biomarkers and the association between poor cardiovascular health and incident dementia: The UK Biobank study Beydoun M., Beydoun H., Hu Y. et al. Olink Explore 3072/384CVDNeurologyPathophysiologyPlasma | | | | |
Molecular & Cellular Proteomics, 2024 Pericyte-Specific Secretome Profiling in Hypoxia Using TurboID in a Multicellular in Vitro Spheroid Model Enström A., Carlsson R., Buizza C. et al. Olink Target 96NeurologyPathophysiologyTechnical EvaluationCell Culture Supernatant | | | | |
Medicine, 2024 Exploring the casual association between gut microbiome, circulating inflammatory cytokines and chronic pancreatitis: A Mendelian randomization analysis Yang X., Xu H., Liang X. et al. Olink Target 96Other Diseases & SyndromesPathophysiologyPlasma | | | | |
Cell Reports Medicine, 2024 Metabolic liability for weight gain in early adulthood Murthy V., Mosley J., Perry A. et al. Olink Target 96Metabolic DiseasesPathophysiologyPlasma | | | | |
International Journal of Molecular Sciences, 2024 Examination of the Complex Molecular Landscape in Obesity and Type 2 Diabetes Vadadokhau U., Varga I., Káplár M. et al. Olink Explore 3072/384Metabolic DiseasesPathophysiologyPatient StratificationPlasma | | | | |